NASDAQ:NTLA | Free Cash Flow | Intellia Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$117.35M$79,000.00-$117.43M
2025-12-31-$69.29M$126,000.00-$69.41M
2025-03-31-$148.93M$735,000.00-$149.67M
2024-12-31-$85.2M$981,000.00-$86.18M
2024-03-31-$120.66M$2.51M-$123.17M
2023-12-31-$93.05M$1.52M-$94.57M
2023-03-31-$109.33M$3.83M-$113.16M
2022-12-31-$89.87M$3.91M-$93.78M
2022-03-31-$79.8M$1.43M-$81.23M
2021-12-31-$54.65M$2.87M-$57.52M
2021-03-31-$52.38M$2.41M-$54.79M
2020-12-31-$40.23M$1.01M-$41.23M
2020-03-31-$38.55M$845,000.00-$39.39M
2019-12-31-$28.66M$2.57M-$31.23M
2019-03-31-$21.45M$1.53M-$22.99M
2018-12-31-$8.54M$1.59M-$10.13M
2018-03-31-$17.77M$1.85M-$19.62M
2017-12-31-$21.31M$2.4M-$23.7M
2017-03-31-$11.4M$4.16M-$15.56M
2016-12-31-$14.41M$3.41M-$17.82M
2016-03-31-$9.42M$1.01M-$10.43M
2015-12-31-$5.49M$849,000.00-$6.34M
2015-03-31$4.82M$516,000.00$4.31M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$394.74M$1.13M-$395.87M
2024-12-31-$348.88M$5.78M-$354.66M
2023-12-31-$394.09M$13.99M-$408.07M
2022-12-31-$333.29M$13.56M-$346.85M
2021-12-31-$225.03M$12.76M-$237.79M
2020-12-31-$49.91M$3.59M-$53.5M
2019-12-31-$103.24M$6.79M-$110.03M
2018-12-31-$61.26M$6.36M-$67.62M
2017-12-31-$65.28M$10.09M-$75.37M
2016-12-31$36.11M$6.17M$29.94M
2015-12-31-$1.76M$2.55M-$4.32M